Turning non-head first twins to head first position before delivery
External Cephalic Version (ECV) for Twins With Non-vertex Presenting Twin
This study is testing a procedure to see if it can safely turn the non-head first twin to a head-down position in women who are close to their due date.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Shaare Zedek Medical Center Academic / other |
| Locations | 1 site (Jerusalem) |
| Trial ID | NCT05894785 on ClinicalTrials.gov |
What this trial studies
This study involves women with a twin pregnancy where the presenting twin is not in a head-down position. Participants will undergo an external cephalic version (ECV) procedure to attempt to turn the non-vertex presenting twin to a vertex position before delivery. The study aims to assess the effectiveness and safety of this intervention in improving delivery outcomes for these pregnancies. The focus is on women who are at term and have not had a previous cesarean delivery.
Who should consider this trial
Good fit: Ideal candidates are multiparous women aged 18 or older with a dichorionic diamniotic twin pregnancy at term and a non-vertex presenting twin.
Not a fit: Patients who are nulliparous or have a monochorionic diamniotic pregnancy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could reduce the need for cesarean deliveries in twin pregnancies with a non-vertex presenting twin.
How similar studies have performed: Other studies have shown that external cephalic version can be effective in improving outcomes for singleton pregnancies, but its application in twin pregnancies is less established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years old or older multiparous no previous cesarean delivery (CD) a non-vertex presenting twin in a term (37 weeks gestation and onwards) dichorionic diamniotic twin pregnancy Exclusion Criteria: * contraindication for a vaginal delivery nulliparous monochorionic diamniotic pregnancy
Where this trial is running
Jerusalem
- Shaare Zedek Medical Center — Jerusalem, Israel (Recruiting)
Study contacts
- Study coordinator: Zvi Ehrlich
- Email: ehrlichz@szmc.org.il
- Phone: +9726555562
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.